Literature DB >> 20610709

JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy.

Chen S Tan1, Laura C Ellis, Christian Wüthrich, Long Ngo, Thomas A Broge, Jenny Saint-Aubyn, Janice S Miller, Igor J Koralnik.   

Abstract

JC virus (JCV) is latent in the kidneys and lymphoid organs of healthy individuals, and its reactivation in the context of immunosuppression may lead to progressive multifocal leukoencephalopathy (PML). Whether JCV is present in the brains or other organs of healthy people and in immunosuppressed patients without PML has been a matter of debate. We detected JCV large T DNA by quantitative PCR of archival brain samples of 9/24 (38%) HIV-positive PML patients, 5/18 (28%) HIV-positive individuals, and 5/19 (26%) HIV-negative individuals. In the same samples, we detected JCV regulatory region DNA by nested PCR in 6/19 (32%) HIV-positive PML patients, 2/11 (18%) HIV-positive individuals, and 3/17 (18%) HIV-negative individuals. In addition, JCV DNA was detected in some spleen, lymph node, bone, and kidney samples from the same groups. In situ hybridization data confirmed the presence of JCV DNA in the brains of patients without PML. However, JCV proteins (VP1 or T antigen) were detected mainly in the brains of 23/24 HIV-positive PML patients, in only a few kidney samples of HIV-positive patients, with or without PML, and rarely in the bones of HIV-positive patients with PML. JCV proteins were not detected in the spleen or lymph nodes in any study group. Furthermore, analysis of the JCV regulatory region sequences showed both rearranged and archetype forms in brain and extraneural organs in all three study groups. Regulatory regions contained increased variations of rearrangements correlating with immunosuppression. These results provide evidence of JCV latency in the brain prior to severe immunosuppression and suggest new paradigms in JCV latency, compartmentalization, and reactivation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610709      PMCID: PMC2937633          DOI: 10.1128/JVI.00609-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

Review 1.  A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region.

Authors:  P N Jensen; E O Major
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

Review 2.  Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.

Authors:  Chen S Tan; Igor J Koralnik
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

3.  High incidence of urinary JC virus excretion in nonimmunosuppressed older patients.

Authors:  T Kitamura; Y Aso; N Kuniyoshi; K Hara; Y Yogo
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

4.  Typing of human polyomavirus JC virus on the basis of restriction fragment length polymorphisms.

Authors:  Y Yogo; T Iida; F Taguchi; T Kitamura; Y Aso
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

5.  Immunocytochemical search for JC papovavirus large T-antigen in multiple sclerosis brain tissue.

Authors:  G L Stoner; C F Ryschkewitsch; D L Walker; D Soffer; H D Webster
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

6.  Interaction of the human polyomavirus, JCV, with human B-lymphocytes.

Authors:  W J Atwood; K Amemiya; R Traub; J Harms; E O Major
Journal:  Virology       Date:  1992-10       Impact factor: 3.616

7.  Evidence of human polyomavirus BK and JC infection in normal brain tissue.

Authors:  C Elsner; K Dörries
Journal:  Virology       Date:  1992-11       Impact factor: 3.616

8.  JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy.

Authors:  F A White; M Ishaq; G L Stoner; R J Frisque
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

9.  Distribution of nonintegrated DNA from JC papovavirus in organs of patients with progressive multifocal leukoencephalopathy.

Authors:  B W Grinnell; B L Padgett; D L Walker
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

10.  Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues.

Authors:  P M Chesters; J Heritage; D J McCance
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

View more
  41 in total

1.  JC virus quasispecies analysis reveals a complex viral population underlying progressive multifocal leukoencephalopathy and supports viral dissemination via the hematogenous route.

Authors:  Tom Van Loy; Kim Thys; Caroline Ryschkewitsch; Ole Lagatie; Maria C Monaco; Eugene O Major; Luc Tritsmans; Lieven J Stuyver
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  JC virus promoter/enhancers contain TATA box-associated Spi-B-binding sites that support early viral gene expression in primary astrocytes.

Authors:  Leslie J Marshall; Lisa D Moore; Matthew M Mirsky; Eugene O Major
Journal:  J Gen Virol       Date:  2011-11-09       Impact factor: 3.891

Review 3.  Progressive multifocal leukoencephalopathy: clinical and molecular aspects.

Authors:  Eleonora Tavazzi; Martyn K White; Kamel Khalili
Journal:  Rev Med Virol       Date:  2011-09-21       Impact factor: 6.989

4.  JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis.

Authors:  Spyridon Chalkias; Xin Dang; Evelyn Bord; Marion C Stein; R Philip Kinkel; Jacob A Sloane; Maureen Donnelly; Carolina Ionete; Maria K Houtchens; Guy J Buckle; Stephanie Batson; Igor J Koralnik
Journal:  Ann Neurol       Date:  2014-06-10       Impact factor: 10.422

5.  Role for tumor necrosis factor-α in JC virus reactivation and progressive multifocal leukoencephalopathy.

Authors:  Hassen S Wollebo; Mahmut Safak; Luis Del Valle; Kamel Khalili; Martyn K White
Journal:  J Neuroimmunol       Date:  2010-12-24       Impact factor: 3.478

6.  Polyomavirus JC urinary shedding in kidney and liver transplant recipients associated with reduced creatinine clearance.

Authors:  Shimon Kusne; Regis A Vilchez; Preeti Zanwar; Jorge Quiroz; Marek J Mazur; Raymond L Heilman; David Mulligan; Janet S Butel
Journal:  J Infect Dis       Date:  2012-07-16       Impact factor: 5.226

7.  Cooperative roles of NF-κB and NFAT4 in polyomavirus JC regulation at the KB control element.

Authors:  Hassen S Wollebo; Sonia Melis; Kamel Khalili; Mahmut Safak; Martyn K White
Journal:  Virology       Date:  2012-06-30       Impact factor: 3.616

8.  Imperfect Symmetry of Sp1 and Core Promoter Sequences Regulates Early and Late Virus Gene Expression of the Bidirectional BK Polyomavirus Noncoding Control Region.

Authors:  Tobias Bethge; Elvis Ajuh; Hans H Hirsch
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

Review 9.  Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies.

Authors:  Eric M L Williamson; Joseph R Berger
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

10.  Frequent infection of neurons by SV40 virus in SIV-infected macaque monkeys with progressive multifocal leukoencephalopathy and meningoencephalitis.

Authors:  Saravanan Kaliyaperumal; Xin Dang; Christian Wuethrich; Heather L Knight; Christine Pearson; John MacKey; Keith G Mansfield; Igor J Koralnik; Susan V Westmoreland
Journal:  Am J Pathol       Date:  2013-10-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.